Currently operating direct organizations across 21 countries, distributing pharmaceuticals to more than 70 markets worldwide, and employing nearly 6,000 professionals, Abdi İbrahim continues its strategic global expansion. Beyond its advanced manufacturing, R&D, and biotechnology complexes in Turkey, the company runs international manufacturing hubs in Kazakhstan (24 million units annual capacity) and Algeria (51 million units annual capacity).
Commencing activities with a dedicated in-country team in Skopje, Abdi İbrahim hosted local healthcare professionals, regulatory authorities, and industry stakeholders to introduce its regional healthcare roadmap.
Five Targeted Therapeutic Categories
Addressing local disease burdens and medication access, the North Macedonian operational pipeline prioritizes:
Respiratory Care
Central Nervous System (CNS)
Cardiovascular Diseases
Pain Management
Consumer Healthcare (OTC)
The company's commercial execution is structured around four primary objectives: expanding patient access to essential and advanced treatment options, deepening clinical partnerships with local institutions, tailoring product portfolios to specific demographic needs, and deploying high-integrity pharmaceutical distribution networks supported by continuous medical education programs.
Executive Commentary
Köksal Ülgen, Group President of International Markets at Abdi İbrahim:
“Our 114-year heritage, industrial and R&D capabilities, biotechnology competencies, and sustainability vision are driving Abdi İbrahim’s growth as a resilient international healthcare company. Expanding into North Macedonia carries this legacy into a strategic new market. Sustainable growth requires a precise understanding of each territory's local healthcare dynamics and regulatory priorities. In North Macedonia, we have established our local operational structure and aligned our therapeutic portfolio with clinical needs. Our commitment is to work hand-in-hand with medical professionals to secure reliable patient access to critical treatments while building a lasting presence.”
Natasha Poposka, Country Manager for North Macedonia at Abdi İbrahim:
“We aim to serve as a reliable, long-term partner to North Macedonia’s healthcare ecosystem. Our focus centers on understanding patient needs, collaborating closely with healthcare professionals and institutions, and supporting therapy access through scientific engagement. Resilient partnerships and mutual trust form the foundation of our sustainable development in the country.”
